SCHEMBL7952025

SCHEMBL7952025

Cc1cc(/C=C(/C#N)S(=O)(=O)c2ccc(F)cc2)cc(C)c1O

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 3/20 0.61
L3MBTL1 Q9Y468 2/20 0.61
PTGS1 P23219 5/20 0.50
PTGS2 P35354 5/20 0.50
HPGD P15428 3/20 0.50
ALOX5 P09917 2/20 0.50
KMT2A Q03164 4/20 0.49
MEN1 O00255 3/20 0.49
ALDH1A1 P00352 2/20 0.49
KDM4E B2RXH2 1/20 0.49
POLB P06746 1/20 0.49
GAA P10253 1/20 0.49
ALPG P10696 1/20 0.49
ALOX15 P16050 1/20 0.49
ALOX12 P18054 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
HSD17B10 Q99714 1/20 0.49
TDP1 Q9NUW8 1/20 0.49
PPME1 Q9Y570 3/20 0.47
EGFR P00533 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7952024 1.00 PKM (0.61) PKML3MBTL1PTGS1PTGS2HPGD
SCHEMBL7952026 1.00 PKM (0.61) PKML3MBTL1PTGS1PTGS2HPGD
SCHEMBL4072666 0.87 PKM (0.50) PKML3MBTL1PTGS1PTGS2HPGD
SCHEMBL4077040 0.87 PKM (0.50) PKML3MBTL1PTGS1PTGS2HPGD
SCHEMBL4072664 0.87 PKM (0.50) PKML3MBTL1PTGS1PTGS2HPGD
SCHEMBL7163929 0.86 ALDH1A1 (0.65) PKML3MBTL1PTGS1PTGS2HPGD
SCHEMBL5373107 0.86 ALDH1A1 (0.65) PKML3MBTL1PTGS1PTGS2HPGD
SCHEMBL7163931 0.86 ALDH1A1 (0.65) PKML3MBTL1PTGS1PTGS2HPGD
SCHEMBL7962841 0.86 HPGD (0.47) PKML3MBTL1PTGS1HPGDKMT2A
SCHEMBL7962839 0.86 HPGD (0.47) PKML3MBTL1PTGS1HPGDKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5891917-A MODULATING TYROSINE SIGNAL TRANSDUCTION TO PREVENT AND TREAT CELL PROLIFERATIVE DISORDERS OR CELL DIFFERENTIATION DISORDERS ASSOCIATED WITH PARTICULAR TYROSINE KINASES BY INHIBITING ONE OR MORE ABNORMAL TYROSINE KINASE ACTIVITIES SUGEN, INC. (US) 1999-04-06 US claimed
WO-1996040629-A1 TYRPHOSTIN-LIKE COMPOUNDS FOR THE TREATMENT OF CELL PROLIFERATIVE DISORDERS OR CELL DIFFERENTIATION DISORDERS SUGEN, INC. (US) 1996-12-19 WO claimed
US-6225346-B1 FOR THERAPY AND PROPHYLAXIS OF CELL PROLIFERATIVE DISORDERS OR CELL DIFFERENTIATION DISORDERS ASSOCIATED WITH PARTICULAR TYROSINE KINASES BY INHIBITING ONE OR MORE ABNORMAL TYROSINE KINASE ACTIVITIES SUGEN, INC. 2001-05-01 US disclosed
US-5935993-A TYROSINE KINASE INHIBITORS; TREATMENT OF CELL GROWTH, CELL DIFFERENTIATION DISORDERS SUGEN, INC. (US) 1999-08-10 US disclosed
US-5891917-A MODULATING TYROSINE SIGNAL TRANSDUCTION TO PREVENT AND TREAT CELL PROLIFERATIVE DISORDERS OR CELL DIFFERENTIATION DISORDERS ASSOCIATED WITH PARTICULAR TYROSINE KINASES BY INHIBITING ONE OR MORE ABNORMAL TYROSINE KINASE ACTIVITIES SUGEN, INC. (US) 1999-04-06 US disclosed
WO-1996040629-A1 TYRPHOSTIN-LIKE COMPOUNDS FOR THE TREATMENT OF CELL PROLIFERATIVE DISORDERS OR CELL DIFFERENTIATION DISORDERS SUGEN, INC. (US) 1996-12-19 WO disclosed